2021
DOI: 10.1038/s41598-020-79791-0
|View full text |Cite
|
Sign up to set email alerts
|

Comprehensive study of antimicrobial susceptibility pattern and extended spectrum beta-lactamase (ESBL) prevalence in bacteria isolated from urine samples

Abstract: Nowadays, increasing extended-spectrum β-lactamase (ESBL)-producing bacteria have become a global concern because of inducing resistance toward most of the antimicrobial classes and making the treatment difficult. In order to achieve an appropriate treatment option, identification of the prevalent species which generate ESBL as well as their antibiotic susceptibility pattern is essential worldwide. Hence, this study aimed to investigate the prevalence of ESBL-producing bacteria and assess their drug susceptibi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

9
35
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 63 publications
(46 citation statements)
references
References 47 publications
9
35
2
Order By: Relevance
“…The inappropriate and indiscriminate use of broad-spectrum antibiotics and prolonged hospital stay are key etiological factors associated with MDR infections ( Prestinaci et al, 2015 ). In our study, 40.4% of E. coli produced ESBLs, whereas other publications reported 25.2%; 35.7, 46.0, and 52–67% ( Gharavi et al, 2021 ; Huang et al, 2022 ; Naushad et al, 2022 ; Sadeghi et al, 2022 ). ESBL producers hydrolyze and eliminate the majority of broad-spectrum beta-lactam antibiotics, increasing morbidity and mortality ( Mahmud et al, 2020 ).…”
Section: Discussioncontrasting
confidence: 77%
“…The inappropriate and indiscriminate use of broad-spectrum antibiotics and prolonged hospital stay are key etiological factors associated with MDR infections ( Prestinaci et al, 2015 ). In our study, 40.4% of E. coli produced ESBLs, whereas other publications reported 25.2%; 35.7, 46.0, and 52–67% ( Gharavi et al, 2021 ; Huang et al, 2022 ; Naushad et al, 2022 ; Sadeghi et al, 2022 ). ESBL producers hydrolyze and eliminate the majority of broad-spectrum beta-lactam antibiotics, increasing morbidity and mortality ( Mahmud et al, 2020 ).…”
Section: Discussioncontrasting
confidence: 77%
“…The prevalence of ESBL-producing bacterial strains among isolated organisms has progressively increased over the past decades [12,16]. In addition, due to cross-resistance to other antimicrobial agents, the therapeutic options in UTIs caused by ESBL-producing microbes are limited, which makes the treatment more complex and the use of broad-spectrum antibiotics expensive [17][18][19][20][21]. Because of this global rise in MDR over time, the significant difference in antimicrobial susceptibility in different geographical regions, the prevalence of the ESBL strain among clinical isolates, and the routine assessment of the antimicrobial susceptibility pattern, resistance surveillance at local, national, and international levels is of paramount importance to facilitate the selection of empiric UTIs therapy.…”
Section: Introductionmentioning
confidence: 99%
“…For interpretation of the results, the bacterial growth inhibition zones ≥22 mm for ceftazidime, ≥27 mm for cefotaxime, and ≥25 mm for ciprofloxacin, were considered for detect-ing broad-spectrum β-lactamase producing isolates. The results announced according to CLSI document M100-18 (31,32).…”
Section: Esbl Resistance Patternsmentioning
confidence: 99%